CD34 and neoplasm: In PC-3 tumor tissues, combined treatment resulted in a remarkable decrease of CD31 and CD34 (60.87% and 56.1% respectively) expression in comparision with vehicle treated group (P<0.01), while the reduce rate were 26.09% for CD31, 39.02% for CD34 in quercetin applied group and 43.38% for CD31, 36.59% for CD34 in 2-ME used group (Fig 8A, 8B, 8D and 8E).